Patent ID: 7427628

Claim:
A method for treating an inflammatory disease mediated by α 4 integrins in a patient said disease selected from the group consisting of asthma, Crohn's disease and multiple sclerosis, which method comprises administering a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound Formula (I) or a pharmaceutically acceptable salt thereof: wherein each X is independently fluoro, chloro or bromo; p is an integer from 0 to 3; R 1 and R 3 together with the nitrogen atom to which they are bound form an azetidinyl, pyrrolidinyl, pyrrolyl, 2,5-dihydopyrrol-1-yl, piperidinyl, or 1,2,3,6-tetrahydro-pyridin-1-yl; and R 2 is selected from the group consisting of lower alkyl, lower alkenyl, and lower alkylenecycloalkyl.